Looking at possible cr scenario.
Currently there are 394,331,169 shares on issue.
Let's say the cr is offered to shareholders on the bases of 1 new share for every 4 shares held, rounded off that would make 98,582,792 shares to be offered.
Let's say they are issued at a discount of 10% on yesterdays closing price .305 - .03 =.275.
98,572,792 x .275 = around $27.1m less cost
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1140
-
- There are more pages in this discussion • 285 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.010(4.44%) |
Mkt cap ! $95.68M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 21.3¢ | $125.5K | 578.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 144480 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 318615 | 3 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |